Hot Melt Extrusion as Solvent-Free Technique for a Continuous Manufacturing of Drug-Loaded Mesoporous Silica

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Hot Melt Extrusion as Solvent-Free Technique for a Continuous Manufacturing of Drug-Loaded Mesoporous Silica. / Genina, Natalja; Hadi, Batol; Löbmann, Korbinian.

In: Journal of Pharmaceutical Sciences, Vol. 107, No. 1, 01.2018, p. 149-155.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Genina, N, Hadi, B & Löbmann, K 2018, 'Hot Melt Extrusion as Solvent-Free Technique for a Continuous Manufacturing of Drug-Loaded Mesoporous Silica', Journal of Pharmaceutical Sciences, vol. 107, no. 1, pp. 149-155. https://doi.org/10.1016/j.xphs.2017.05.039

APA

Genina, N., Hadi, B., & Löbmann, K. (2018). Hot Melt Extrusion as Solvent-Free Technique for a Continuous Manufacturing of Drug-Loaded Mesoporous Silica. Journal of Pharmaceutical Sciences, 107(1), 149-155. https://doi.org/10.1016/j.xphs.2017.05.039

Vancouver

Genina N, Hadi B, Löbmann K. Hot Melt Extrusion as Solvent-Free Technique for a Continuous Manufacturing of Drug-Loaded Mesoporous Silica. Journal of Pharmaceutical Sciences. 2018 Jan;107(1):149-155. https://doi.org/10.1016/j.xphs.2017.05.039

Author

Genina, Natalja ; Hadi, Batol ; Löbmann, Korbinian. / Hot Melt Extrusion as Solvent-Free Technique for a Continuous Manufacturing of Drug-Loaded Mesoporous Silica. In: Journal of Pharmaceutical Sciences. 2018 ; Vol. 107, No. 1. pp. 149-155.

Bibtex

@article{f5e63ca7e8764fe586cddf012496ed18,
title = "Hot Melt Extrusion as Solvent-Free Technique for a Continuous Manufacturing of Drug-Loaded Mesoporous Silica",
abstract = "The aim of this study is to explore hot melt extrusion (HME) as a solvent-free drug loading technique for preparation of stable amorphous solid dispersions using mesoporous silica (PSi). Ibuprofen and carvedilol were used as poorly soluble active pharmaceutical ingredients (APIs). Due to the high friction of an API:PSi mixture below the loading limit of the API, it was necessary to add the polymer Soluplus({\textregistered}) (SOL) in order to enable the extrusion process. As a result, the APIs were distributed between the PSi and SOL phase after HME. Due to its higher affinity to PSi, ibuprofen was mainly adsorbed into the PSi, whereas carvedilol was mainly found in the SOL phase. Intrinsic dissolution rate was highest for HME formulations, containing PSi, compared to pure crystalline (amorphous) APIs and HME formulations without PSi. HME is a feasible solvent-free drug loading technique for preparation of PSi-based amorphous solid dispersions.",
keywords = "Journal Article",
author = "Natalja Genina and Batol Hadi and Korbinian L{\"o}bmann",
note = "Copyright {\textcopyright} 2017 American Pharmacists Association{\textregistered}. Published by Elsevier Inc. All rights reserved.",
year = "2018",
month = jan,
doi = "10.1016/j.xphs.2017.05.039",
language = "English",
volume = "107",
pages = "149--155",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "Elsevier",
number = "1",

}

RIS

TY - JOUR

T1 - Hot Melt Extrusion as Solvent-Free Technique for a Continuous Manufacturing of Drug-Loaded Mesoporous Silica

AU - Genina, Natalja

AU - Hadi, Batol

AU - Löbmann, Korbinian

N1 - Copyright © 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

PY - 2018/1

Y1 - 2018/1

N2 - The aim of this study is to explore hot melt extrusion (HME) as a solvent-free drug loading technique for preparation of stable amorphous solid dispersions using mesoporous silica (PSi). Ibuprofen and carvedilol were used as poorly soluble active pharmaceutical ingredients (APIs). Due to the high friction of an API:PSi mixture below the loading limit of the API, it was necessary to add the polymer Soluplus(®) (SOL) in order to enable the extrusion process. As a result, the APIs were distributed between the PSi and SOL phase after HME. Due to its higher affinity to PSi, ibuprofen was mainly adsorbed into the PSi, whereas carvedilol was mainly found in the SOL phase. Intrinsic dissolution rate was highest for HME formulations, containing PSi, compared to pure crystalline (amorphous) APIs and HME formulations without PSi. HME is a feasible solvent-free drug loading technique for preparation of PSi-based amorphous solid dispersions.

AB - The aim of this study is to explore hot melt extrusion (HME) as a solvent-free drug loading technique for preparation of stable amorphous solid dispersions using mesoporous silica (PSi). Ibuprofen and carvedilol were used as poorly soluble active pharmaceutical ingredients (APIs). Due to the high friction of an API:PSi mixture below the loading limit of the API, it was necessary to add the polymer Soluplus(®) (SOL) in order to enable the extrusion process. As a result, the APIs were distributed between the PSi and SOL phase after HME. Due to its higher affinity to PSi, ibuprofen was mainly adsorbed into the PSi, whereas carvedilol was mainly found in the SOL phase. Intrinsic dissolution rate was highest for HME formulations, containing PSi, compared to pure crystalline (amorphous) APIs and HME formulations without PSi. HME is a feasible solvent-free drug loading technique for preparation of PSi-based amorphous solid dispersions.

KW - Journal Article

U2 - 10.1016/j.xphs.2017.05.039

DO - 10.1016/j.xphs.2017.05.039

M3 - Journal article

C2 - 28603020

VL - 107

SP - 149

EP - 155

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 1

ER -

ID: 185405121